Skip to Content
scroll

ResMed Inc (RMD) $29.01

RMD announced yesterday the $1.45bn purchase of Germanys healthcare platform MediFox Dan, a leader in Out-of-Hospital software solutions. We like the general direction the company is moving with this being its 3rd and largest acquisition in the software space although the expansion into Europe may prove a slow but steady process. The deal is to be funded by existing credit facilities which is encouraging as a capital raise won’t be required later in the year.

  • Technically RMD will look really good into fresh 12-month lows under $27 and we may tweak our position higher into such a move.
RMD
MM likes RMD into further weakness
Add To Hit List
chart
image description
ResMed Inc (RMD)
Back to top